Thermaiscan

Curated by Signal

AI-based breast cancer diagnosis and detection software for providers

Overview

AI-based breast cancer diagnosis and detection software for providers. The companies product helps in the early detection of breast cancer among patients. It provides an AI-enabled thermal camera and smartphone that can scan and detect any abnormality in the tissues and symptoms. The medical device is a portable risk assessment tool that assists with cancer pre-screening processes using the use of thermal imaging technology.

Key facts

Founded: 2021
Headquarters: United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

CyPath Lung
Provider of a non-invasive lung cancer detection test
Life Sciences TechnologySan Antonio, United States
INDUSTRIAL & BIOMEDICAL SENSORS CORPORATION
Developer of non-invasive blood pressure monitors
Life Sciences TechnologyWaltham, United States
IBS
Developer of saliva-based glucose test for diabetes
Life Sciences TechnologyNew York City, United States

About Thermaiscan

What does Thermaiscan do?

AI-based breast cancer diagnosis and detection software for providers.

Where is Thermaiscan headquartered?

Thermaiscan is headquartered in United States.

When was Thermaiscan founded?

Thermaiscan was founded in 2021.

Which sector is Thermaiscan in?

Thermaiscan operates in Life Sciences Technology.

Who are Thermaiscan's competitors?

Companies similar to Thermaiscan include CyPath Lung, INDUSTRIAL & BIOMEDICAL SENSORS CORPORATION, and IBS.